NAME | SIZE | ES | NES | FDR |
---|---|---|---|---|
Enriched gene sets in HPGF-C18 group (FDRÂ <Â 0.25) | ||||
 HALLMARK_CHOLESTEROL_HOMEOSTASIS | 24 | 0.87 | 2.21 | 0.00 |
 HALLMARK_MTORC1_SIGNALING | 59 | 0.60 | 1.99 | 0.02 |
 HALLMARK_ANDROGEN_RESPONSE | 20 | 0.56 | 1.87 | 0.02 |
 KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 26 | 0.53 | 1.86 | 0.02 |
 HALLMARK_MITOTIC_SPINDLE | 49 | 0.71 | 1.88 | 0.02 |
 RESPONSE_TO_DNA_DAMAGE_STIMULUS | 38 | 0.69 | 1.89 | 0.02 |
 KEGG_P53_SIGNALING_PATHWAY | 20 | 0.69 | 1.89 | 0.02 |
 LIPID_BIOSYNTHETIC_PROCESS | 32 | 0.52 | 1.90 | 0.03 |
 NUCLEOCYTOPLASMIC_TRANSPORT | 20 | 0.69 | 1.83 | 0.03 |
 KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 25 | 0.72 | 1.91 | 0.03 |
 HALLMARK_INTERFERON_ALPHA_RESPONSE | 31 | 0.59 | 1.81 | 0.03 |
 M_PHASE | 38 | 0.72 | 1.74 | 0.04 |
 DNA_METABOLIC_PROCESS | 65 | 0.59 | 1.75 | 0.04 |
 CELL_CYCLE_PROCESS | 62 | 0.69 | 1.75 | 0.04 |
 HALLMARK_ADIPOGENESIS | 39 | 0.47 | 1.73 | 0.04 |
 DNA_REPAIR | 26 | 0.72 | 1.75 | 0.04 |
 CELL_CYCLE_GO_0007049 | 95 | 0.57 | 1.77 | 0.04 |
 HALLMARK_APOPTOSIS | 57 | 0.44 | 1.73 | 0.04 |
 DNA_RECOMBINATION | 15 | 0.80 | 1.75 | 0.04 |
 CELL_CYCLE_PHASE | 56 | 0.67 | 1.76 | 0.04 |
 HALLMARK_INTERFERON_GAMMA_RESPONSE | 63 | 0.48 | 1.77 | 0.05 |
 CHROMOSOME_ORGANIZATION_AND_BIOGENESIS | 24 | 0.63 | 1.78 | 0.05 |
 NUCLEAR_TRANSPORT | 21 | 0.66 | 1.77 | 0.05 |
 RESPONSE_TO_ENDOGENOUS_STIMULUS | 50 | 0.55 | 1.71 | 0.05 |
 KEGG_CELL_CYCLE | 45 | 0.73 | 1.70 | 0.05 |
 MITOTIC_CELL_CYCLE | 50 | 0.69 | 1.71 | 0.05 |
 BIOCARTA_HIVNEF_PATHWAY | 17 | 0.59 | 1.70 | 0.05 |
 MICROTUBULE_BASED_PROCESS | 25 | 0.62 | 1.70 | 0.05 |
 HALLMARK_DNA_REPAIR | 22 | 0.66 | 1.69 | 0.06 |
 CELL_CYCLE_CHECKPOINT_GO_0000075 | 20 | 0.74 | 1.68 | 0.06 |
 ESTABLISHMENT_OF_CELLULAR_LOCALIZATION | 71 | 0.42 | 1.66 | 0.07 |
 KEGG_OOCYTE_MEIOSIS | 31 | 0.56 | 1.66 | 0.07 |
 GAMETE_GENERATION | 37 | 0.47 | 1.66 | 0.07 |
 PROTEIN_TARGETING | 22 | 0.59 | 1.64 | 0.07 |
 ESTABLISHMENT_OF_PROTEIN_LOCALIZATION | 40 | 0.47 | 1.63 | 0.07 |
 KEGG_APOPTOSIS | 21 | 0.53 | 1.64 | 0.07 |
 HALLMARK_G2M_CHECKPOINT | 68 | 0.78 | 1.64 | 0.07 |
 M_PHASE_OF_MITOTIC_CELL_CYCLE | 26 | 0.75 | 1.64 | 0.07 |
 MACROMOLECULE_LOCALIZATION | 47 | 0.47 | 1.64 | 0.07 |
 ORGANELLE_ORGANIZATION_AND_BIOGENESIS | 118 | 0.41 | 1.62 | 0.07 |
 REGULATION_OF_CELL_CYCLE | 57 | 0.53 | 1.62 | 0.07 |
 MITOSIS | 26 | 0.75 | 1.64 | 0.07 |
 CELLULAR_LOCALIZATION | 74 | 0.41 | 1.61 | 0.08 |
 DNA_DEPENDENT_DNA_REPLICATION | 15 | 0.70 | 1.61 | 0.08 |
 PROTEIN_TRANSPORT | 35 | 0.47 | 1.60 | 0.08 |
 CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS | 71 | 0.40 | 1.58 | 0.10 |
 DNA_REPLICATION | 26 | 0.63 | 1.58 | 0.10 |
 KEGG_PEROXISOME | 21 | 0.46 | 1.57 | 0.10 |
 CELL_MIGRATION | 26 | 0.43 | 1.56 | 0.11 |
 HALLMARK_ESTROGEN_RESPONSE_EARLY | 63 | 0.40 | 1.56 | 0.11 |
 PROTEIN_LOCALIZATION | 42 | 0.46 | 1.56 | 0.11 |
 DETECTION_OF_STIMULUS | 19 | 0.55 | 1.55 | 0.11 |
 HALLMARK_IL2_STAT5_SIGNALING | 59 | 0.37 | 1.54 | 0.12 |
 INTRACELLULAR_PROTEIN_TRANSPORT | 30 | 0.49 | 1.53 | 0.12 |
 INTERPHASE | 22 | 0.60 | 1.53 | 0.12 |
 CELL_PROLIFERATION_GO_0008283 | 185 | 0.34 | 1.53 | 0.12 |
 HALLMARK_E2F_TARGETS | 60 | 0.72 | 1.52 | 0.13 |
 INTERPHASE_OF_MITOTIC_CELL_CYCLE | 19 | 0.61 | 1.51 | 0.13 |
 SEXUAL_REPRODUCTION | 48 | 0.46 | 1.51 | 0.13 |
 ORGAN_MORPHOGENESIS | 54 | 0.37 | 1.50 | 0.14 |
 ANATOMICAL_STRUCTURE_MORPHOGENESIS | 118 | 0.33 | 1.50 | 0.14 |
 HALLMARK_UV_RESPONSE_UP | 49 | 0.37 | 1.49 | 0.15 |
 KEGG_PYRIMIDINE_METABOLISM | 22 | 0.55 | 1.48 | 0.16 |
 NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS | 263 | 0.34 | 1.48 | 0.16 |
 RESPONSE_TO_STRESS | 140 | 0.32 | 1.46 | 0.17 |
 TRANSLATION | 30 | 0.42 | 1.46 | 0.17 |
 HALLMARK_SPERMATOGENESIS | 47 | 0.45 | 1.45 | 0.18 |
 ACTIN_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS | 38 | 0.36 | 1.45 | 0.18 |
 KEGG_BASAL_CELL_CARCINOMA | 16 | 0.47 | 1.41 | 0.22 |
 HALLMARK_TNFA_SIGNALING_VIA_NFKB | 69 | 0.38 | 1.39 | 0.24 |
Enriched gene sets in FBS group (FDRÂ <Â 0.25) | ||||
 HALLMARK_GLYCOLYSIS | 54 | 0.56 | 1.97 | 0.02 |
 ACTIVATION_OF_MAPK_ACTIVITY | 15 | 0.65 | 1.73 | 0.14 |
 POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY | 17 | 0.63 | 1.72 | 0.14 |
 KEGG_CELL_ADHESION_MOLECULES_CAMS | 48 | 0.49 | 1.68 | 0.15 |
 KEGG_ECM_RECEPTOR_INTERACTION | 33 | 0.54 | 1.74 | 0.15 |
 KEGG_FOCAL_ADHESION | 61 | 0.43 | 1.66 | 0.16 |
 HALLMARK_HYPOXIA | 66 | 0.51 | 1.68 | 0.16 |
 KEGG_TGF_BETA_SIGNALING_PATHWAY | 25 | 0.55 | 1.68 | 0.17 |
 EXTRACELLULAR_STRUCTURE_ORGANIZATION_AND_BIOGENESIS | 16 | 0.73 | 1.74 | 0.18 |
 FEMALE_PREGNANCY | 21 | 0.59 | 1.75 | 0.23 |
 HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 79 | 0.51 | 1.78 | 0.23 |
 TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY | 18 | 0.54 | 1.60 | 0.25 |